Navigation Links
Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
Date:12/14/2009

ion of lung cancer," Dr. Schwebel said. "We are excited to have Clarient, with its long history of collaborating with academia and innovative companies in developing novel oncology tests utilizing biomarkers, as our first partner to develop a test based on our proprietary probes and technologies. We are confident that our collaboration with Clarient will successfully help to develop, validate and commercialize the test through its established pathways to the market."

Clarient Chief Executive Officer Ron Andrews said the test could become a very valuable tool for detecting lung cancer and for expanding Clarient's lung cancer franchise. "This test has promise to become a valuable diagnostic and prognostic tool for determining the risk of lung cancer for many patients, but particularly for smokers," Andrews said. "Lung cancer continues to be an area of focus in the coming months for Clarient and we are particularly interested in working with pharmaceutical companies that are developing smoking cessation drugs. We look forward to our collaboration with BioView on these confirmatory studies and possible commercialization of this test."

Andrews estimated that the validation studies should be completed during 2010.

About BioView Ltd.

Established in 2000, and led by an expert team of biologists, software engineers and physicists, BioView develops, manufactures and supplies cell imaging equipment, biological kits and software to medical institutes and universities. BioView is a publicly traded company on the Israeli Stock exchange, and currently has strategic collaborations underway with international scientific leaders and institutions. For more information about the BioView technology, and press related issues, please contact alan@bioview.co.il or visit our website at www.bioview.
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test
2. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
3. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
4. Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients
5. New Research Shows Over-use of Asthma Rescue Inhalers Substantially Reduced Through Pharmacist-initiated Physician Intervention
6. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
7. Incept BioSystems Initiates First Human Clinical Trial of its SMART Embryo Culture System for In Vitro Fertilization (IVF)
8. Abbotts XIENCE V(R) Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS(R) Liberte in Investigator-Initiated COMPARE Trial
9. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
10. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
11. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  ArmaGen, Inc., a privately held ... treat severe neurological disorders, announced today that the ... Phase 1/2a clinical trial of AGT-181 in patients ... AGT-181 is an investigational enzyme replacement ... The most severe form of MPS I, Hurler ...
(Date:9/2/2015)... , Sept. 2, 2015 Unilife Corporation ("Unilife" ... UNS), a developer, manufacturer and supplier of injectable drug ... initiated expressions of interest, the Company,s Board of Directors ... a review of strategic alternatives to maximize shareholder value. ... and evaluated during the review process may include a ...
(Date:9/2/2015)... , September 2, 2015 According ... by Product (Digital & Computed Radiography, Ultrasound, Computed & ... PACS) by Application (Oncology, Cardiology, Neurology) - Global Forecast ... to reach USD 2.8 Billion by 2020 growing at ... Br owse 240 Tables and 44 ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Unilife Announces Review of Strategic Alternatives 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5
(Date:9/3/2015)... ... September 03, 2015 , ... ... Bob Anders and Kelley Chapman will be joining the company’s executive leadership team ... Anders has over 30 years’ experience in healthcare product and project management. He ...
(Date:9/3/2015)... ... 03, 2015 , ... The partnership will leverage Fidson’s strong ... services to promote LodonalTM in Nigeria. The distribution will become effective, upon completion ... of the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed ...
(Date:9/2/2015)... ... , ... The Aspen Clinic (TAC), located in Basalt, Colorado, today ... inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, Executive Director ... to fitness - we are much more than a gym. Our fitness and ...
(Date:9/2/2015)... ... ... One can hardly argue against the fact that more and more people ... These devices are being used as GPS, to make purchases, and yes, even to ... positive singles can now join the prestigious social ranks of e-dating. , Recently, ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 03, 2015 ... ... stacks of nominations to determine who among America’s policymakers, public servants, activists, corporate ... on the nation’s health care. This year, that process led the magazine to ...
Breaking Medicine News(10 mins):Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3
... Report Injects a Dose of Reality into the Debate on the State ... ... The AIDS Vaccine Advocacy,Coalition (AVAC) today released a new report that ... 2008:,The Search Must Continue explores the issues that have been raised in ...
... 15 HealthSTAR Public Relations, LLC,(HSPR) announced today that ... President., Prior to joining HSPR, Soffer managed the ... She has 14,years of industry experience at agencies including ... the majority of her career. She began,her career at ...
... shown that an electric shock ranging from 120 to ... humans. , Following an electrical injury, some patients ... memory loss and symptoms of depression. , The ... by clinicians from the Universit de Montrals Faculty of ...
... live, LAVAL, QC, May 15 /PRNewswire-FirstCall/ - ... as Neurochem Inc.) announces today that on,Monday, May ... and Chief Executive Officer will present BELLUS Health,s ... Healthcare Conference to be,held at the Le Meridien ...
... and Control for Lead ... Removal, ... today announced the availability of the new LLD,EZ Lead Locking Device (LLD) ... EZ enables physicians to secure,the entire lead creating traction to enable the ...
... obese and lead unhealthy lifestyles are more likely to ... to a population-based study of more than 5,000 men ... UK-based urology journal BJU International. Researchers hope the results ... how they can be managed more effectively. , ...
Cached Medicine News:Health News:Immunizing Against Misinformation and Shortsightedness 2Health News:Immunizing Against Misinformation and Shortsightedness 3Health News:Immunizing Against Misinformation and Shortsightedness 4Health News:HealthSTAR Public Relations Hires Hayley Soffer, Executive Vice President 2Health News:Electric shocks can cause neurologic and neuropsychological symptoms 2Health News:BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference 2Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 2Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 2Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 4
... is an off-the-shelf wrist orthotic designed to limit the ... ranges-of-motion (20°,35° and 50°). , ,Indications: , ... tear-triangular fibrocartilage complex , Coles fracture - ... Partial tendon rupture , ORIF - ...
Contoured design provides secure support and immobilization of the wrist and distal forearm while preserving finger mobility...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: